Tyra Biosciences, Inc.(NASDAQ:TYRA) 
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatm...
Website: http://www.tyra.bio
Founded: 2018
CEO / Co-Founder: Todd Harris
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.94
H 8.13
L 7.52
C 7.74
V 482,596
10EMA 7.74
20EMA 7.74
60EMA 7.74
120EMA 7.74
250EMA 7.74